20-49070216-A-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP3BS2
The NM_001316.4(CSE1L):c.687A>T(p.Glu229Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000389 in 1,284,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001316.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSE1L | NM_001316.4 | c.687A>T | p.Glu229Asp | missense_variant | 8/25 | ENST00000262982.3 | NP_001307.2 | |
CSE1L | NM_001362762.2 | c.687A>T | p.Glu229Asp | missense_variant | 8/25 | NP_001349691.1 | ||
CSE1L | NM_001256135.2 | c.687A>T | p.Glu229Asp | missense_variant | 8/24 | NP_001243064.1 | ||
CSE1L | NR_045796.2 | n.325A>T | non_coding_transcript_exon_variant | 5/22 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSE1L | ENST00000262982.3 | c.687A>T | p.Glu229Asp | missense_variant | 8/25 | 1 | NM_001316.4 | ENSP00000262982.2 | ||
CSE1L | ENST00000396192.7 | c.687A>T | p.Glu229Asp | missense_variant | 8/24 | 5 | ENSP00000379495.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000389 AC: 5AN: 1284434Hom.: 0 Cov.: 20 AF XY: 0.00000465 AC XY: 3AN XY: 644732
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.687A>T (p.E229D) alteration is located in exon 8 (coding exon 7) of the CSE1L gene. This alteration results from a A to T substitution at nucleotide position 687, causing the glutamic acid (E) at amino acid position 229 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.